Table_1_Exosome-Transmitted miR-25 Induced by H. pylori Promotes Vascular Endothelial Cell Injury by Targeting KLF2.DOCX
Background: Increasing evidence has shown that Helicobacter pylori is associated with coronary heart disease (CHD); however, the underlying mechanism remains unclear.
Methods: The expression of miR-25 and mRNAs was measured using qRT-PCR. Protein levels were detected using western blotting and exosomes were assessed with an electron microscope. The target gene of miR-25 was identified using the luciferase report system.
Results:H. pylori infection increased the expression of miR-25 in gastric epithelial cells and was associated with increased levels of exosome-transmitted miR-25 in human peripheral blood. Mechanistic investigation showed the Kruppel-like factor 2 (KLF2) was a direct target of exosome-transmitted miR-25 in vascular endothelial cells. In addition, the miR-25/KLF2 axis regulated the NF-κB signaling pathway, resulting in increased expression of interleukin 6 (IL6), monocyte chemoattractant protein-1 (MCP-1), vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 (ICAM-1).
Conclusion: Our findings suggest that the miR-25/KLF2 axis may be a potential therapeutic target for H. pylori-associated CHD. Furthermore, high levels of exosome-transmitted miR-25 in peripheral blood may pose a potential risk for CHD.
History
References
- https://doi.org//10.1053/euhj.1997.0618
- https://doi.org//10.1385/CRIAI:18:1:73
- https://doi.org//10.1016/j.cmet.2018.09.011
- https://doi.org//10.5551/jat.25775
- https://doi.org//10.1038/ncb2441
- https://doi.org//10.3390/ijms18112383
- https://doi.org//10.1056/NEJMc1805129
- https://doi.org//10.1016/S0021-9150(98)00194-4
- https://doi.org//10.1371/journal.pone.0041629
- https://doi.org//10.1161/01.RES.0000159707.05637.a1
- https://doi.org//10.1016/j.immuni.2011.04.014
- https://doi.org//10.1007/s11010-015-2614-9
- https://doi.org//10.1016/j.jhep.2012.08.026
- https://doi.org//10.1016/j.ijcard.2007.08.052
- https://doi.org//10.1016/B978-0-12-386930-2.00007-0
- https://doi.org//10.1161/CIRCRESAHA.117.311428
- https://doi.org//10.3892/mmr.2015.3329
- https://doi.org//10.1016/S0140-6736(99)04470-0
- https://doi.org//10.18632/oncotarget.24662
- https://doi.org//10.1038/nrcardio.2015.38
- https://doi.org//10.1146/annurev-pathol-012615-044135
- https://doi.org//10.1084/jem.20031132
- https://doi.org//10.1016/j.exger.2018.09.009
- https://doi.org//10.1002/0471143030.cb0322s30
- https://doi.org//10.1016/j.cell.2016.01.043
- https://doi.org//10.1038/ncb1596
- https://doi.org//10.1161/JAHA.117.007134
- https://doi.org//10.1007/s10096-017-3054-0
- https://doi.org//10.1038/s41556-018-0083-6
- https://doi.org//10.14744/AnatolJCardiol.2018.43255
- https://doi.org//10.1016/j.jacc.2018.08.2161
- https://doi.org//10.1016/j.ccr.2014.03.007
CC BY 4.0